Fig. 5From: Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinomaKaplan–Meier curves for progression-free survival (PFS) (A) and overall survival (OS) (B) of all 33 patients. MTT, molecular targeted therapy; CRT, chemoradiotherapyBack to article page